Market Closed -
Nyse
01:30:02 05/06/2024 am IST
5-day change
1st Jan Change
18.62
USD
+0.43%
-17.65%
-19.57%
Presentation Operator MessageOperator (Operator)Good morning, ladies and gentlemen, and welcom...
Truist Securities Adjusts Price Target on Phreesia to $29 From $35, Maintains Buy Rating
03/06
MT
Transcript : Phreesia, Inc., Q1 2025 Earnings Call, May 30, 2024
31/05
Phreesia Fiscal Q1 Net Loss Narrows, Revenue Increases; Lowers Fiscal 2025 Revenue Outlook
31/05
MT
Earnings Flash (PHR) PHREESIA Reports Q1 Revenue $101.2M
31/05
MT
Phreesia, Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024
31/05
CI
Phreesia, Inc. Updates Earnings Guidance for the Year 2025
31/05
CI
Phreesia Insider Sold Shares Worth $610,684, According to a Recent SEC Filing
26/03
MT
JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating
21/03
MT
Phreesia Names Jack Callahan as Chief Technology Officer
19/03
MT
Phreesia Appoints Jack Callahan as Chief Technology Officer
19/03
CI
Baird Adjusts Price Target on Phreesia to $31 From $30, Maintains Outperform Rating
18/03
MT
Raymond James Raises Phreesia's Price Target to $30 From $25, Maintains Outperform Rating
15/03
MT
Canaccord Genuity Adjusts Price Target on Phreesia to $37 From $36, Maintains Buy Rating
15/03
MT
RBC Raises Price Target on Phreesia to $23 From $17, Cites 'Encouraging Progress Toward Profitability,' Keeps Sector Perform Rating
15/03
MT
Transcript : Phreesia, Inc., Q4 2024 Earnings Call, Mar 14, 2024
15/03
Phreesia Fiscal Q4 Net Loss Narrows, Revenue Increases; FY 2025 Revenue Outlook Maintained; Shares Rise After Hours
15/03
MT
Phreesia Guides For FY 2025 Revenue of $424-$434 Million, vs CIQ Analyst Consensus of $428 Million
15/03
MT
Earnings Flash (PHR) PHREESIA Posts Q4 Revenue $95M, vs. Street Est of $93.5M
15/03
MT
Phreesia, Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024
15/03
CI
Phreesia, Inc. Reports Earnings Results for the Full Year Ended January 31, 2024
15/03
CI
Truist Securities Initiates Phreesia at Buy Rating With $35 Price Target
26/02
MT
Phreesia Insider Sold Shares Worth $1,630,138, According to a Recent SEC Filing
19/01
MT
Phreesia Insider Sold Shares Worth $1,046,093, According to a Recent SEC Filing
19/01
MT
Phreesia Insider Sold Shares Worth $796,441, According to a Recent SEC Filing
19/01
MT
Phreesia Insider Sold Shares Worth $458,552, According to a Recent SEC Filing
19/01
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
More about the company
Last Close Price
18.62
USD
Average target price
29.12
USD
Spread / Average Target
+56.42%
Consensus
1st Jan change
Capi.
-19.57% 1.07B +10.66% 3,092B +9.13% 86.07B +5.43% 78.64B -16.13% 53.11B +28.71% 49.21B +31.31% 46.21B -33.61% 41.11B +73.04% 40.25B +3.06% 28.44B
Other Software
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1